HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang-Chang Wu Selected Research

Acetogenins

11/2004Montacin and cis-montacin, two new cytotoxic monotetrahydrofuran annonaceous acetogenins from Annona montana.
10/2004Nine new cytotoxic monotetrahydrofuranic Annonaceous acetogenins from Annona montana.
7/2003Acetogenins as selective inhibitors of the human ovarian 1A9 tumor cell line.
3/2003New adjacent Bis-tetrahydrofuran Annonaceous acetogenins from Annona muricata.
4/2002New cytotoxic monotetrahydrofuran annonaceous acetogenins from Annona muricata.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang-Chang Wu Research Topics

Disease

93Neoplasms (Cancer)
02/2022 - 05/2003
17Breast Neoplasms (Breast Cancer)
03/2021 - 08/2005
15Inflammation (Inflammations)
06/2022 - 02/2010
9Leukemia
10/2016 - 06/2004
8Hepatocellular Carcinoma (Hepatoma)
01/2015 - 04/2002
7Infections
01/2022 - 01/2011
7Lung Neoplasms (Lung Cancer)
03/2018 - 08/2004
6Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 07/2003
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2012
6Liver Neoplasms (Liver Cancer)
01/2018 - 01/2006
5Mouth Neoplasms (Oral Cancer)
03/2018 - 04/2010
4Body Weight (Weight, Body)
06/2022 - 06/2012
4Rheumatoid Arthritis
01/2022 - 10/2005
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 05/2003
4Prostatic Neoplasms (Prostate Cancer)
10/2016 - 06/2008
3Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2003
3Osteoarthritis
01/2022 - 01/2017
3Triple Negative Breast Neoplasms
05/2021 - 03/2015
3Wounds and Injuries (Trauma)
03/2021 - 12/2004
3Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 01/2018
3Carcinogenesis
04/2019 - 01/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2019 - 04/2011
3Hyperlipidemias (Hyperlipidemia)
06/2018 - 12/2017
3Neoplasm Metastasis (Metastasis)
12/2015 - 01/2012
3Ataxia Telangiectasia (Louis Bar Syndrome)
06/2015 - 07/2012
3Mitochondrial Diseases (Mitochondrial Disease)
05/2014 - 12/2011
3Colorectal Neoplasms (Colorectal Cancer)
06/2013 - 04/2010
2COVID-19
01/2022 - 08/2021
2Experimental Arthritis
01/2022 - 01/2022
2Hypertension (High Blood Pressure)
01/2021 - 08/2013
2Peptic Ulcer (Peptic Ulcers)
01/2021 - 01/2011
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 10/2005

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
13Pharmaceutical PreparationsIBA
03/2021 - 02/2009
12protoapigenoneIBA
01/2020 - 09/2005
11FlavonoidsIBA
01/2020 - 09/2005
10Superoxides (Superoxide)IBA
06/2022 - 02/2010
9Pancreatic Elastase (Elastase)IBA
06/2022 - 02/2010
7Phosphotransferases (Kinase)IBA
01/2022 - 06/2008
6Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018 - 12/2009
6AlkaloidsIBA
01/2018 - 07/2003
6goniothalaminIBA
01/2015 - 02/2005
5CytokinesIBA
01/2022 - 01/2005
5DNA (Deoxyribonucleic Acid)IBA
03/2018 - 02/2010
5Biological ProductsIBA
01/2017 - 01/2006
5AcetogeninsIBA
11/2004 - 04/2002
4Cisplatin (Platino)FDA LinkGeneric
02/2022 - 07/2012
4SteroidsIBA
10/2021 - 06/2008
4Estrogen ReceptorsIBA
03/2021 - 04/2011
4WithanolidesIBA
02/2019 - 05/2007
4LipopolysaccharidesIBA
01/2017 - 01/2005
4EstersIBA
01/2017 - 11/2003
4CaspasesIBA
12/2015 - 08/2005
3Ursolic AcidIBA
01/2022 - 01/2006
3Antiviral Agents (Antivirals)IBA
01/2022 - 09/2009
3antcin KIBA
01/2022 - 01/2012
3EnzymesIBA
03/2021 - 12/2011
3PhytochemicalsIBA
01/2020 - 01/2017
3Acetylcysteine (Siran)FDA LinkGeneric
03/2018 - 12/2009
3AcidsIBA
01/2017 - 10/2005
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2017 - 09/2015
3norcantharidinIBA
10/2016 - 04/2010
3WYC02-9IBA
12/2013 - 05/2011
3Matrix Metalloproteinases (MMPs)IBA
07/2013 - 08/2010
3Annexin A5IBA
06/2013 - 09/2012
3Caspase 3 (Caspase-3)IBA
01/2013 - 03/2012
3TriterpenesIBA
12/2012 - 08/2005
3LactonesIBA
09/2012 - 05/2007
3Mitogen-Activated Protein KinasesIBA
04/2012 - 04/2011
3DiterpenesIBA
03/2012 - 07/2009
3Histones (Histone)IBA
12/2011 - 02/2009
3AntioxidantsIBA
12/2011 - 07/2005
3squamocinIBA
02/2011 - 01/2006
3Vincristine (Oncovin)FDA LinkGeneric
02/2010 - 08/2008
3tetrahydrofuranIBA
01/2006 - 03/2003
2LipidsIBA
06/2022 - 01/2017
2dehydroeburicoic acidIBA
06/2022 - 11/2016
2Fatty Acids (Saturated Fatty Acids)IBA
06/2022 - 01/2017
2fuzi drug herbalIBA
05/2022 - 01/2021
2Aurora Kinase AIBA
02/2022 - 01/2022
2Peptides (Polypeptides)IBA
02/2022 - 03/2021
2Ethanol (Ethyl Alcohol)IBA
01/2022 - 02/2019
2Plant ExtractsIBA
10/2021 - 06/2018
2Protease Inhibitors (Protease Inhibitor)IBA
01/2021 - 12/2017
2abacavir (Ziagen)FDA Link
01/2021 - 01/2018
2Reverse Transcriptase InhibitorsIBA
01/2021 - 12/2017
2LopinavirFDA Link
01/2021 - 01/2018
2Checkpoint Kinase 1IBA
01/2021 - 06/2015
2Lamivudine (Epivir)FDA Link
01/2021 - 01/2018
2Ritonavir (Norvir)FDA Link
01/2021 - 01/2018
2NucleosidesIBA
01/2021 - 12/2017
2Zidovudine (Retrovir)FDA LinkGeneric
01/2021 - 01/2018
2NucleotidesIBA
01/2021 - 01/2021
2Checkpoint Kinase 2IBA
01/2021 - 06/2015

Therapy/Procedure

26Therapeutics
02/2022 - 10/2010
6Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 12/2002
6Drug Therapy (Chemotherapy)
01/2016 - 07/2011
4Traditional Medicine (Folk Remedies)
11/2018 - 08/2013
3Art Therapy
01/2021 - 12/2017
3Oral Administration
07/2018 - 12/2002